In vitro hemolysis: guidance for the pharmaceutical scientist

Journal of Pharmaceutical Sciences
Ketan Amin, Rose-Marie Dannenfelser

Abstract

Pharmaceutical excipients are commonly incorporated into parenteral formulations to increase solubility and stability of active pharmaceutical ingredients. The biocompatibility of these excipients is an important consideration during formulation development. Despite the importance of hemolytic potential of parenteral formulations, there is considerable contradictory information in the literature related to the hemolytic potential of various excipients. The hemolytic potential of various formulation vehicles in dog, rabbit, and human blood by means of an in vitro hemolysis assay is compared. The selected formulation vehicles are found in currently marketed drug products. The guidance presented here considers formulations with a hemolysis value of <10% to be nonhemolytic while values > 25% to be at risk for hemolysis.

References

Dec 31, 1997·Journal of Pharmaceutical Sciences·J F KrzyzaniakS H Yalkowsky
May 30, 2003·The Annals of Pharmacotherapy·Lawrence A Trissel, Quanyun A Xu

❮ Previous
Next ❯

Citations

Jul 9, 2008·Nano Letters·Marina A DobrovolskaiaScott E McNeil
May 9, 2012·Drug Design, Development and Therapy·Olivier LambertNagesh Palepu
Jan 25, 2014·Journal of Pharmacy & Bioallied Sciences·Maheshkumar P SoniPadma V Devarajan
Feb 18, 2015·Drug Development and Industrial Pharmacy·Sandeep Kumar SinghPrabhat Ranjan Mishra
Dec 19, 2013·Drug Delivery·Harikrishna DevalapallySvitlana Silchenko
Jan 29, 2016·Langmuir : the ACS Journal of Surfaces and Colloids·Abhishek BaralArindam Banerjee
Apr 23, 2013·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Kristof KovacsIlona Petrikovics
Apr 25, 2012·International Journal of Pharmaceutics·Adel S AbdelrahimIstvan Toth
Nov 29, 2015·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Smita K Pawar, Pradeep Vavia
Jan 18, 2012·Journal of Peptide Science : an Official Publication of the European Peptide Society·Veronika TørfossMorten B Strøm
Oct 15, 2013·The Journal of Pharmacy and Pharmacology·Lissinda H du PlessisAwie F Kotzé
Jul 16, 2013·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Mohammed ElmowafyMarjo Yliperttula
Oct 12, 2016·Molecular Pharmaceutics·Smita S Kale, Krishnacharya G Akamanchi
Mar 28, 2017·Bioconjugate Chemistry·Chelladurai Karthikeyan BalavigneswaranNira Misra
Feb 24, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Yueli BaoMinglong Yuan
Feb 7, 2013·Pharmacological Reviews·Hywel D WilliamsChristopher J H Porter
Jun 3, 2017·Drug Development and Industrial Pharmacy·Saurabh SarkarBodhisattwa Chaudhuri
Dec 14, 2019·Brazilian Journal of Microbiology : [publication of the Brazilian Society for Microbiology]·Lívia do Carmo SilvaMaristela Pereira
Jun 9, 2020·Preparative Biochemistry & Biotechnology·Mina SepahiDariush Norouzian
Jul 1, 2020·Biopolymers·Chelladurai Karthikeyan BalavigneswaranNira Misra
Oct 19, 2017·Scientific Reports·Jyothi U MenonKytai T Nguyen
Aug 23, 2018·Drug Delivery and Translational Research·Jasmin MonparaPradeep Vavia
Aug 13, 2017·Applied Microbiology and Biotechnology·Ali GhasemiBahareh Dabirmanesh
Dec 14, 2013·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Qi ZhangZheng Wang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
Kohsaku KawakamiYasuo Ida
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
Kristóf KovácsKrisztina Ludányi
© 2022 Meta ULC. All rights reserved